Bed Bath & Beyond Files 8-K with Financials and Other Events

TL;DR

BBB filed an 8-K on 9/22/25 - check financials and other events.

AI Summary

On September 22, 2025, Bed Bath & Beyond, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. The company's principal executive offices are located at 433 W. Ascension Way, 3rd Floor, Murray, Utah 84123.

Why It Matters

This filing provides updated financial information and disclosures for Bed Bath & Beyond, Inc., which is crucial for investors and stakeholders to assess the company's current financial health and operational status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K report, primarily containing financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.

Key Players & Entities

• BED BATH & BEYOND, INC. (company) — Registrant
• 433 W. Ascension Way, 3rd Floor, Murray, Utah 84123 (location) — Principal executive offices
• September 22, 2025 (date) — Date of Report

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value per share BBBY New York S
• $15.50 — warrants will have an exercise price of $15.50 per share and will expire on October 7,

Filing Documents

• ef20055884_8k.htm (8-K) — 32KB
• ef20055884_99-1.htm (EX-99.1) — 10KB
• ef20055884_99-2.htm (EX-99.2) — 30KB
• image0.jpg (GRAPHIC) — 45KB
• 0001140361-25-035644.txt ( ) — 274KB
• byon-20250922.xsd (EX-101.SCH) — 4KB
• byon-20250922_lab.xml (EX-101.LAB) — 21KB
• byon-20250922_pre.xml (EX-101.PRE) — 16KB
• ef20055884_8k_htm.xml (XML) — 4KB

01

Item 8.01 Other Events. On September 22, 2025, Bed Bath & Beyond, Inc. (the "Company") issued a press release announcing that the Board of Directors of the Company had declared a warrant dividend distribution (the "Warrant Distribution") to the record holders of the Company's common stock, par value $0.0001 per share (the "Common Stock"), in the form of warrants to purchase Common Stock (the "Warrants"). The Warrants will be distributed on or around October 7, 2025 to the record holders of Common Stock as of the close of business on October 2, 2025 (the "Record Date"). Holders of Common Stock will receive one (1) warrant for each ten (10) shares of Common Stock, rounded down to the nearest whole number. The warrants will have an exercise price of $15.50 per share and will expire on October 7, 2026. We intend to apply for the warrants to be listed on the New York Stock Exchange to facilitate trading, which may begin under ticker symbol BBBYW on the first day of trading following the distribution date. The foregoing description is only a summary and is qualified in its entirety by reference to the press release, which is filed as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

01

Item 7.01 Regulation FD Disclosure. In connection with the press release described in Item 8.01 above, the Company will make available a document containing questions and answers (the "FAQ") regarding the Warrant Distribution on the Warrant Dividend section of the Company's Investor Relations website. The FAQ is attached as Exhibit 99.2 to this Form 8-K. The information furnished in this Current Report under Item 7.01 Regulation FD Disclosure, including Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing. No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The issuance of the Warrants in the Warrant Distribution has not been registered under the Securities Act, as the distribution of a Warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants will be filed with the Securities and Exchange Commission (the "SEC") and will be available on the SEC's website located at http://www.sec.gov. Holders of Common Stock should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This communication contains a general summary of the Warrants. Please read the warrant agreeme

Forward Looking Statements

Forward Looking Statements This Form 8-K and the exhibits attached to this Form 8-K contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning the anticipated warrant distribution, including: our expectations regarding the warrant dividend and distribution; the anticipated record date and distribution date for the warrant distribution; the potential aggregate gross proceeds from warrant exercises; the expected use of proceeds from any proceeds received from warrant exercises; the acceptance of trading of the warrants on the New York Stock Exchange; the price of those warrants and the existence of a market for those warrants; and the participation in the warrant distribution. These forward-looking statements are based on the Company's current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause Company's actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. These risks include, but are not limited to market risks, trends and conditions. These and other risks are more fully described in the Company's filings with the SEC, including in the section entitled "Risk Factors" in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2025 and June 30, 2025, and other filings and reports that the Company may file from time to time with the SEC.

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release Issued September 22, 2025 99.2 Warrant Dividend Distribution FAQ, dated September 22, 2025 104 The XBRL tags on the cover page of this Form 8-K are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEYOND, INC. By: /s/ ADRIANNE B. LEE Adrianne B. Lee President and Chief Financial Officer Date: September 22, 2025

View Full Filing

View this 8-K filing on SEC EDGAR